Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 65.48 PB Ratio: 6.45 GF Score: 92/100

Bio-Techne Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 13, 2020 / 01:40PM GMT
Release Date Price: €64.5
Derik De Bruin
BofA Merrill Lynch, Research Division - MD of Equity Research

Hey, everyone. This is Derik De Bruin, the Life Sciences and Diagnostics Tools analyst for Bank of America. Welcome to our Virtual Vegas Health Care Conference, Day 2. Thank you, everybody, for dialing in and those of you on the line, I hope that you're enjoying this new experiment in remote conferences.

Our next company up today is Bio-Techne. With us from Bio-Techne is Chuck Kummeth, Chief Executive Officer; and Jim Hippel, Chief Financial Officer. Chuck, Jim, welcome. Thanks for being here.

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Thank you.

James T. Hippel
Bio-Techne Corporation - Senior VP of Finance & CFO

You bet (inaudible)

Derik De Bruin
BofA Merrill Lynch, Research Division - MD of Equity Research

So I think -- yes, go ahead. Yes. I was going to say, Chuck, I think you've got a few slides to go through, and then I'm going to follow it

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot